Getinge (OTCMKTS:GNGBY) Upgraded to "Hold" at Zacks Research

Key Points

• Getinge was upgraded to a "Hold" by Zacks Research, and the stock opened at $20.69 on Thursday, trading up about 1.2%.
• In its last quarter Getinge reported $0.47 EPS on $1.08 billion in revenue, with a return on equity of 10.6% and a net margin of 6.54%; sell-side analysts forecast about 1.26 EPS for the current year.
• Getinge is a global medical technology company focused on critical care, surgical workflows and infection control, offering products such as sterilization equipment, ventilation systems and ECMO devices.

Getinge (OTCMKTS:GNGBY - Get Free Report) was upgraded by research analysts at Zacks Research to a "hold" rating in a note issued to investors on Thursday,Zacks.com reports.

Getinge Trading Up 1.2%

Getinge stock opened at $20.69 on Thursday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.32 and a quick ratio of 0.86. Getinge has a one year low of $18.70 and a one year high of $24.67. The stock has a market capitalization of $5.64 billion, a PE ratio of 24.06 and a beta of 1.10. The business's fifty day moving average is $20.89 and its 200 day moving average is $22.20.

Getinge (OTCMKTS:GNGBY - Get Free Report) last released its quarterly earnings data on Tuesday, January 27th. The company reported $0.47 EPS for the quarter. Getinge had a return on equity of 10.60% and a net margin of 6.54%.The company had revenue of $1.08 billion for the quarter. On average, sell-side analysts predict that Getinge will post 1.26 EPS for the current year.

Getinge Company Profile

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company's offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge's solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company's product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.